The negative effect of urologic chronic pelvic pain syndrome on female sexual function: a systematic review and meta-analysis
Introduction and hypothesis
To explore the effect of urologic chronic pelvic pain syndrome (UCPPS) on female sexual function.
Database searches were conducted in PubMed, EMBASE, the Cochrane Library, and Google Scholar for published literature using the Female Sexual Function Index (FSFI) or reporting the prevalence of dyspareunia. Data extraction and quality evaluation were performed on the literature that met the inclusion criteria, and a meta-analysis was performed using STATA 12.0 and RevMan5.3 software to calculate the mean differences (MD) and odds ratios (OR) and their 95% confidence intervals (CI).
A total of nine case-control studies enrolling 4965 subjects were investigated. The present meta-analysis results demonstrated a strong correlation between UCPPS and dyspareunia (OR = 11.27, 95% CI: 5.15–24.67, P < 0.00001). The UCPPS group had significantly lower scores in each domain of the FSFI compared with the healthy control group: total score (MD = −11.35, 95% CI: −14.54– − 8.16, P < 0.00001); desire (MD = −1.04, 95% CI: −1.20– − 0.88, P < 0.00001); arousal (MD = −1.78, 95% CI: −2.36– − 1.20, P < 0.00001); lubrication (MD = −2.11, 95% CI: −2.49– − 1.73, P < 0.00001); orgasm (MD = −1.50, 95% CI: −1.72– − 1.28, P < 0.00001); satisfaction (MD = −1.54, 95% CI: −1.97– − 1.12, P < 0.00001); pain (MD = −2.89, 95% CI: −3.63– − 2.14, P < 0.00001).
UCPPS had a significantly negative effect on female sexual function, particularly in the lubrication, pain, and total score domains. In addition, UCPPS patients had a significantly higher risk of dyspareunia. Psychosocial variables may be a potential pathogenesis of female sexual dysfunction (FSD). Future well-designed research is called for to develop a comprehensive estimate of the association between UCPPS and FSD.
KeywordsUrologic chronic pelvic pain syndrome Female sexual dysfunction Female Sexual Function Index Dyspareunia Meta-analysis
We thank Prof. Zhihai Qin for his linguistic assistance and suggestions to improve the manuscript. We thank Prof. Hairong Huang for her assistance with the statistical aspects.
This study was funded by grants from the Natural Science Foundation of Hainan Province (no. 20158296).
Compliance with ethical standards
Conflicts of interest
- 2.Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208. https://doi.org/10.1080/009262300278597.CrossRefPubMedGoogle Scholar
- 5.Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2017. http://www.ohrica/programs/clinical_epidemiology/oxford.asp.
- 14.Schrepf A, O'Donnell M, Luo Y, Bradley CS, Kreder K, Lutgendorf S. Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: associations with painful symptoms. Pain. 2014;155(9):1755–61. https://doi.org/10.1016/j.pain.2014.05.029.CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Engeler DS, Baranowski AP, Dinis-Oliveira P, Elneil S, Hughes J, Messelink EJ, et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol. 2013;64(3):431–9. https://doi.org/10.1016/j.eururo.2013.04.035.CrossRefPubMedGoogle Scholar
- 29.van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7. https://doi.org/10.1016/j.eururo.2007.09.019.CrossRefPubMedPubMedCentralGoogle Scholar